Exclusive: SEC probe of Valeant began with review of short seller ? sources

[ahlam1399]

Exclusive: SEC probe of Valeant began with review of short seller ? sources
NEW YORK (Reuters) - A U.S. regulatory probe of Valeant Pharmaceuticals International Inc , disclosed by the company on Monday, is focused on the drugmaker's relationship with specialty pharmacy Philidor RX Services and was triggered by Valeant’s own request that regulators investigate a short seller's allegations, people familiar with the matter said.
http://i2.wp.com/reuters.us.feedsportal.com/c/35217/f/654200/s/4df82e37/sc/19/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/topNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/topNews?a=cKHNC4w7kd0:M7QkPPbfa2c:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/topNews?i=cKHNC4w7kd0:M7QkPPbfa2c:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/topNews?a=cKHNC4w7kd0:M7QkPPbfa2c:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/topNews?i=cKHNC4w7kd0:M7QkPPbfa2c:-BTjWOF_DHI (http://feeds.reuters.com/~ff/reuters/topNews?a=cKHNC4w7kd0:M7QkPPbfa2c:-BTjWOF_DHI)
http://feeds.feedburner.com/~r/reuters/topNews/~4/cKHNC4w7kd0